Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration of the shared pathways and common biomarkers in cervical and ovarian cancer using integrated bioinformatics analysis. | Discov Oncol | 2024 | 39714743 | PubTator, text mining | PubMed |
| Proteomics and Incident Kidney Failure in Individuals With CKD: The African American Study of Kidney Disease and Hypertension and the Boston Kidney Biopsy Cohort. | Kidney Med | 2024 | 39634331 | PubTator, text mining | PubMed |
| Phosphatidylinositol 4,5-bisphosphate drives the formation of EGFR and EphA2 complexes. | Sci Adv | 2024 | 39630914 | PubTator, text mining | PubMed |
| Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review. | Discov Oncol | 2024 | 39331302 | PubTator, text mining | PubMed |
| HPV-ferroptosis related genes as biomarkers to predict the prognosis of cervical cancer. | Discov Oncol | 2024 | 39302544 | PubTator, text mining | PubMed |
| Comment on, "Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis". | Neurosurg Rev | 2024 | 39271527 | PubTator, text mining | PubMed |
| Vasculogenic mimicry-related gene prognostic index for predicting prognosis, immune microenvironment in clear cell renal cell carcinoma. | Heliyon | 2024 | 39247316 | PubTator, text mining | PubMed |
| Retraction: The expression of ephrinA1/ephA2 receptor increases in chronic rhinosinusitis and ephrinA1/ephA2 signaling affects rhinovirus-induced innate immunity in human sinonasal epithelial cells. | Front Immunol | 2024 | 39035003 | PubTator, text mining | PubMed |
| Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line. | Eur J Med Chem | 2024 | 39024966 | PubTator, text mining | PubMed |
| Combined detection of serum EFNA1 and MMP13 as diagnostic biomarker for gastric cancer. | Sci Rep | 2024 | 38987376 | PubTator, text mining | PubMed |
| Cholesterol inhibits assembly and activation of the EphA2 receptor. | bioRxiv | 2024 | 38915729 | PubTator, text mining | PubMed |
| Preliminary study on the mechanism by which exosomes derived from human exfoliated deciduous teeth improve the proliferation and osteogenic inhibitory effect of glucocorticoid-induced BMSCs. | Gene | 2024 | 38762017 | PubTator, text mining | PubMed |
| Development of a Specific Aptamer-Modified Nano-System to Treat Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2024 | 38704694 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of PDCoV-Infected HIEC-6 Cells and Enrichment Pathways PI3K-Akt and P38 MAPK. | Viruses | 2024 | 38675921 | PubTator, text mining | PubMed |
| Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis. | Sci Transl Med | 2024 | 38657024 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma. | Sci Rep | 2024 | 38528036 | PubTator, text mining | PubMed |
| Comparison of Different Vascular Biomarkers for Predicting In-Hospital Mortality in Severe SARS-CoV-2 Infection. | Microorganisms | 2024 | 38276214 | PubTator, text mining | PubMed |
| Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state. | Cell Death Dis | 2024 | 38272889 | PubTator, text mining | PubMed |
| The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme. | Cells | 2024 | 38247816 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma. | J Int Med Res | 2024 | 38180878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers?page=4